Connect with us

News

AI In Health And Beyond: What To Expect In 2025

Published

on

Artificial Intelligence is progressing quickly. From chatbots to generative AI content, the technology is being used in virtually every industry. And, as it enjoys more widespread use, it is becoming more advanced.

AI content is becoming more difficult to detect, and its use in data analysis is producing results across businesses and industries. In healthcare, as in most industries, AI is being used for everything from communication to automated data analysis and, in 2025, the industry will see greater innovation and improvements.

AI Improvements

The idea of artificial intelligence dates back to the automatons of ancient Greece, although the start of modern AI can be dated to the 1950s, especially Alan Turing’s imitation game (now known as the Turing Test). The technology has become prevalent in the past few years, though, as technology like smartphones and advanced processors have expanded artificial intelligence.

Today, the best AI apps for iPhone can generate AI voices and art. They can also, according to senior technology writer Alice Martin, be used to manage social media. As well as its benefits for personal use, AI is also a powerful tool used in the healthcare industry.

Improved Chatbot Communication

Chatbots can be used to answer quick questions and direct users to appropriate answers. Within the healthcare industry, these tools can be used to answer patient calls and direct the caller to the most appropriate ward or department.

As AI continues to develop, being trained by healthcare and communication specialists, it will be better equipped to deal with more complex enquiries. Although it is still some way off, AI could eventually be used to assist with diagnosis.

Administrative Assistance

As well as being used as chatbots for rapid responses to queries, AI can be deployed as virtual assistants. Virtual assistants are more advanced than chatbots and can manage calendars, arrange and rearrange meetings, and perform other tasks for healthcare professionals. They can also be used to book appointments, send follow-up letters, and offer more advanced features to patients.

Dealing With Data

AI is well-equipped to handle, read, and manipulate large volumes of data. This makes it especially useful for administrative tasks. As well as being able to work with patient data and health records, AI can aid in everything from patient applications to marketing and advertising. Patient data records must be accurate, and different departments and different organizations may hold different data on patients. This data needs to be amalgamated to provide the greatest benefits and assist in accurate diagnoses.

Marketing Prediction

Marketing is another area that relies on the use of large sets of data. It also uses predictive modelling and optimization, and these are areas where artificial intelligence is already well advanced. These marketing features can be used by healthcare institutions and private healthcare facilities, as well as pharmaceutical companies and manufacturers.

The health insurance industry will also benefit from more reliable and targeted marketing campaigns backed by predictive modelling.

Fraud Detection

Fraud is fairly commonplace within the healthcare industry and it is estimated that it costs the industry $250 billion a year or more. Typical fraud cases involve individuals fraudulently making claims against insurance, but they can also involve healthcare facilities and providers altering claims or submitting larger claims than are reasonable. Insurance companies invest large sums to try and identify and combat this type of fraud, and AI is positioned to help.

Machine learning algorithms are used to analyze the behaviors of individuals and healthcare providers. These algorithms can detect any anomalous activity, which may be indicative of fraudulent activity. AI can compare claims to previous claims by the same patient, as well as patterns established across the industry. With more data comes more accurate results, and 2025 is likely to see AI implemented in this way with greater frequency.

Improved AI Diagnostics

The healthcare industry has a wealth of diagnostic tools, with more tests regularly being introduced. Test results can include data provided by the patients themselves to medical imaging, blood tests, and more. Any one of these diagnostic tools can identify potential conditions.

When healthcare providers are looking at diagnostic information, they tend to look for very specific indicators, whereas AI can be used to highlight other, otherwise unseen, symptoms and signs. Various AI companies and specialists are looking at ways to improve AI diagnostics, and even Google is known to be advancing in this area of AI research.

Personalized Medication Plans

Medication plans are used in the treatment of various conditions and can require complex combinations of different types of treatment as well as various medications. AI can analyze patient responses to medication, as well as study treatment outcomes from other patients.

Using this information, AI can potentially develop more accurate and more effective medication plans, and so in real-time, while checking patient records for any potential issues. This also frees up time for healthcare providers to be able to meet with patients and receive diagnostic answers.

Predictive Analytics

Predictive analytics can be used throughout the patient journey, as well as in administrative roles within the healthcare industry. It can be used to predict potential outbreaks of illnesses or to predict the course of an individual’s illness. It can also be used to predict health and wellness epidemics that will sweep through nations, and then to use this and other information to devise action plans to help prevent the spread.

2025 is likely to see further moves into multimodal AI within healthcare. Multimodal AI means taking and using data from multiple sources. This will not only include diagnostic test results, but patient details from other sources.

Medical Claim And Insurance Assessments

Health insurance and medical claims are important components of the healthcare industry. Insurance underwriters use predictive modelling, taking into account patient data and previous health tests, to help determine the risks they pose.

To do this, they need to analyze large data sets related to applicants and the population as a whole. Machine learning algorithms use data that is updated in real-time to assess risks on the fly. AI can also be used to process medical claims and to identify likely fraud.

AI Regulations

AI is an emerging field. Some of the biggest companies in the world are working on their own AI solutions, and it is being implemented in various big industries, including healthcare. While this does mean that the technology continues to advance, it also means that patients and individuals need safeguarding.

As such, governments and government agencies are working on ways to implement safeguarding procedures and policies. 2025 is likely to see further AI regulation, and this will continue, especially as the technology becomes more advanced and as it is used to deal with highly personal information like medical records.

Conclusion

AI is a disruptive technology, and while it certainly isn’t a new technology, it has seen considerable jumps forward in the past few years. As well as being used in the development of different forms of content, it has found use in marketing, communication, and across a host of different industries and markets. Healthcare’s use of big data and its need for up-to-date analysis means that artificial intelligence continues to gain prominence within healthcare companies.

 

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Diagnosis

Lung cancer drug shows breast cancer potential

Published

on

Ovarian cancer cells quickly activate survival responses after PARP inhibitor treatment, and a lung cancer drug could help block this, research suggests.

PARP inhibitors are a common treatment for ovarian cancer, particularly in tumours with faulty DNA repair. They stop cancer cells fixing DNA damage, which leads to cell death, but many tumours later stop responding.

Researchers identified a way cancer cells may survive PARP inhibitor treatment from the outset, pointing to a potential way to block that response. A Mayo Clinic team found ovarian cancer cells rapidly switch on a pro-survival programme after exposure to PARP inhibitors. A key driver is FRA1, a transcription factor (a protein that turns genes on and off) that helps cancer cells adapt and avoid death.

The team then tested whether brigatinib, a drug approved for certain lung cancers, could block this response and boost the effect of PARP inhibitors. Brigatinib was chosen because it inhibits multiple signalling pathways involved in cancer cell survival.

In laboratory studies, combining brigatinib with a PARP inhibitor was more effective than either treatment alone. Notably, the effect was seen in cancer cells but not normal cells, suggesting a more targeted approach.

Brigatinib also appeared to act in an unexpected way. Rather than working through the usual DNA repair routes, it shut down two signalling molecules, FAK and EPHA2, that aggressive ovarian cancer cells rely on. FAK and EPHA2 are proteins that relay survival signals inside cells. Blocking both at once weakened the cells’ ability to adapt and resist treatment, making them more vulnerable to PARP inhibitors.

Tumours with higher levels of FAK and EPHA2 responded better to the drug combination. Other data link high levels of these molecules to more aggressive disease, pointing to potential benefit in harder-to-treat cases.

Arun Kanakkanthara, an oncology investigator at Mayo Clinic and a senior author of the study, said: “This work shows that drug resistance does not always emerge slowly over time; cancer cells can activate survival programmes very early after treatment begins.”

John Weroha, a medical oncologist at Mayo Clinic and a senior author of the study, said: “From a clinical perspective, resistance remains one of the biggest challenges in treating ovarian cancer. By combining mechanistic insights from Dr Kanakkanthara’s laboratory with my clinical experience, this preclinical work supports the strategy of targeting resistance early, before it has a chance to take hold. This strategy could improve patient outcomes.”

Continue Reading

Insight

Higher nighttime temps linked to increased risk of autism diagnosis in children – study

Published

on

Nighttime temperatures during pregnancy may be linked to a higher chance of an autism diagnosis in children, a recent study suggests.

The research tracked nearly 295,000 mother-child pairs in Southern California from 2001 to 2014 and linked warmer overnight temperatures with higher risk in early and late pregnancy.

Children of mothers exposed to higher than typical nighttime temperatures during weeks one to 10 of pregnancy had a 15 per cent higher risk of an autism diagnosis.

Exposure during weeks 30 to 37 was linked to a 13 per cent higher risk.

 Lead author David Luglio, a post-doctoral fellow at Tulane University, said: “A key takeaway is that we identified specific windows when a mother and her developing child can be most affected by exposures to higher nighttime temperatures.

“This is critical and hopefully can help mothers prepare accordingly.”

The study is described as the first to examine how temperature may affect fetal neurodevelopment, the process by which a baby’s brain and nervous system form during pregnancy.

Extreme temperatures linked to increased risk were classified as above the 90th percentile, meaning 3.6°F hotter than average, and the 99th percentile, 5.6°F above average.

The association held even after researchers accounted for factors such as neighbourhood conditions, vegetation and fine-particle air pollution.

The study could not account for other factors such as access to air conditioning. Researchers did not find the same association with daytime temperatures, potentially because people spend more time away from home during the day.

“Heat waves are becoming more frequent, and people may only think of the dangers of daytime heat exposure,” said Mostafijur Rahman, assistant professor of environmental health sciences at Tulane University.

“These results indicate a strong association between high nighttime temperatures during pregnancy and autism risk in children and show that we need to think about exposure to heat around the clock.”

The study did not examine how higher temperatures at night might affect prenatal development, though Luglio said it is possible that warmer nights disrupt sleep for pregnant mothers.

Previous research has suggested insufficient sleep during pregnancy may be linked to a higher risk of neurocognitive delays in children.

“Extreme heat exposure during pregnancy has been linked to a range of adverse health outcomes, including prenatal neurodevelopment delays and complications with an embryo’s development of a central nervous system,” Luglio said.

“The goal of our study was to specifically explore the link between prenatal heat exposure and autism diagnoses for the first time.”

Continue Reading

Entrepreneur

Kindbody unveils next-gen fertility platform

Published

on

Kindbody has launched a fertility platform integrating AI with clinical care and patient support for employers and health plans.

The platform will enter a pilot with select Kindbody employer clients in 2026, covering over three million lives, ahead of wider availability in 2027.

Building on the company’s clinical model, the platform aims to improve outcomes and cost efficiency across family-building journeys. It connects Kindbody-owned clinics, partner clinics and an integrated clinical app.

The app offers virtual care across conception, pregnancy and reproductive health, extending through the menopause transition.

Launch features include updates in medication management, third-party reproduction, adoption, pregnancy, men’s health and global programme design.

David Stern, chief executive of Kindbody, said: “With our next-generation fertility platform, Kindbody is redefining what comprehensive, intelligent and affordable family-building care looks like for employers, health plans and patients.

“By unifying best-in-class clinical care, AI-driven intelligence and whole-person support, we are making it easier and more cost-effective for more people to build the families they envision.”

Kindbody has expanded access via its national network of IVF centres, including IVIRMA, Inception Fertility and Ivy Fertility.

A new Fertility Medication Portal is designed to streamline authorisations so medicines can be dispensed on time, giving patients visibility from prescription to coverage, pharmacy fulfilment and delivery tracking.

Through KindMan, men’s health education, digital resources and integrated clinical care are expanding, including hormone management programmes.

Services cover andropause (age-related testosterone decline), erectile dysfunction, low testosterone and other male reproductive conditions.

Specialist fertility care includes semen analysis, diagnostic testing, male hormone panels, genetic testing, surgical sperm extraction and sperm cryopreservation.

Launching in the second quarter, a pregnancy support app will act as a digital companion for expecting and new parents, with resources, interactive tools and clinical assessments to identify social drivers of health and mental health needs during pregnancy and beyond.

Kindbody’s physician-led menopause programme provides consultations with board-certified obstetricians and gynaecologists to diagnose, treat and manage menopausal symptoms, including hormone replacement therapy where appropriate, with support from nutritionists, mental health therapists and pelvic floor specialists.

AI and analytics will be embedded across the care journey. An AI care navigator will guide employees from benefit activation through intake, triage and scheduling.

Tools will track benefits and treatment plans, showing coverage and expected out-of-pocket costs at each step.

AI-supported scribing will assist clinicians with documentation, and a predictor tool will estimate a patient’s likelihood of having a baby across different treatment paths.

In 2027, Kindbody plans a savings model for eligible large employers that it says will guarantee lower total fertility spend while improving clinical efficiency and patient experience.

Continue Reading

Trending

Copyright © 2025 Aspect Health Media Ltd. All Rights Reserved.